Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Roche Vincent
Over the trailing 90 days, Roche Vincent (Director at ANALOG DEVICES INC) traded $53.9M of stock (net selling $32.3M) in ADI, per 14 SEC Form 4 transactions.
- Role
- Director
- Companies
- ADI
- Window
- Trailing 90 days · 14 transactions · CIK 1201872
- Net activity
- −$32.3M ($10.8M bought · $43.1M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| ADI | ANALOG DEVICES INC | 14 | $10.8M | $43.1M | −$32.3M |
Transactions (14)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-01 | ADI | Sell | 10.0K | $1.1M | Exercise or conversion of derivative security |
| 2026-07-01 | ADI | Buy | 10.0K | $1.1M | Exercise or conversion of derivative security |
| 2026-07-01 | ADI | Sell | 10.0K | $3.9M | Open market or private sale |
| 2026-06-01 | ADI | Sell | 10.0K | $4.0M | Open market or private sale |
| 2026-06-01 | ADI | Sell | 10.0K | $1.1M | Exercise or conversion of derivative security |
| 2026-06-01 | ADI | Buy | 10.0K | $1.1M | Exercise or conversion of derivative security |
| 2026-05-26 | ADI | Buy | 30.0K | $4.3M | Exercise or conversion of derivative security |
| 2026-05-26 | ADI | Sell | 20.0K | $8.3M | Open market or private sale |
| 2026-05-26 | ADI | Sell | 10.0K | $4.1M | Open market or private sale |
| 2026-05-26 | ADI | Sell | 30.0K | $4.3M | Exercise or conversion of derivative security |
| 2026-05-22 | ADI | Buy | 30.0K | $4.3M | Exercise or conversion of derivative security |
| 2026-05-22 | ADI | Sell | 30.0K | $4.3M | Exercise or conversion of derivative security |
| 2026-05-22 | ADI | Sell | 665 | $264K | Open market or private sale |
| 2026-05-22 | ADI | Sell | 29.3K | $11.6M | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Roche's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.